Related Experiment Videos
Expression of TGFalpha in meningiomas
1Department of Pathology, College of Veterinary Medicine, The University of Georgia, Athens 30602-7388, USA. jhalper@calc.vet.uga.edu
Journal of Neuro-Oncology
|April 25, 2000
Summary
Transforming growth factor alpha (TGFalpha) and its receptor are present in most meningiomas. However, their expression levels do not significantly differ across tumor subtypes or grades, limiting their use in classification.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Research
Background:
- Meningiomas are the most common primary intracranial tumors.
- Transforming growth factor alpha (TGFalpha) is a mitogen implicated in various cancers.
- The role of TGFalpha and its receptor in meningioma pathogenesis is not fully understood.
Purpose of the Study:
- To investigate the expression of TGFalpha and its receptor in different meningioma subtypes and grades.
- To determine if TGFalpha expression correlates with meningioma morphology or malignancy.
- To assess the utility of TGFalpha and its receptor as biomarkers for meningioma classification or grading.
Main Methods:
- Immunohistochemistry was used to detect TGFalpha and EGF/TGFalpha receptor protein.
- In situ hybridization (ISH) was employed to analyze TGFalpha mRNA expression.
- Tissues from 26 meningiomas (benign, atypical, malignant) were examined.
Main Results:
- TGFalpha protein expression was strongest in fibrous and atypical meningiomas.
- TGFalpha mRNA was detected in most tumors, with higher signals in malignant types.
- EGF/TGFalpha receptor was expressed in all studied meningiomas.
- No statistically significant differences in expression were found among subtypes or grades.
Conclusions:
- TGFalpha and its receptor are frequently present in meningiomas across all grades.
- The expression patterns do not support a significant role for TGFalpha in meningioma tumorigenesis or progression.
- TGFalpha and its receptor are not useful for classifying or grading meningiomas.